Zenzium provides actionable intelligence that enables improved care outcomes for people with chronic medical conditions.

Using proprietary, as well as open source, data capabilities and machine learning we can discover and extract relevant actionable information from large complex datasets and aggregate real-time data from environmental, personal, wearable and medical devices together with Electronic Medical Records (EMRs) and other historical datasets including proteomic, metabolomic and genomic data.  We then apply algorithms and machine learning to discover patterns that may correlate with events and exacerbations offering a proactive approach to chronic care.

Our Focus

Zenzium’s initial focus is for people with respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF). We are also working with a range of neurodegenerative conditions such as dementia, specifically Alzheimer’s, as well as Multiple Sclerosis (MS) and Cardiovascular Disease (CVD).

The Benefits

Predictive analytics may improve care outcomes, mitigate exacerbations and reduce hospitalizations helping to reduce healthcare costs while optimizing valuable resources.

Our Customers

Zenzium technology is aimed at healthcare providers and carers, but individual or family members may also benefit from its use. Additionally our technology can add insight to medical research, drug development or clinical trials.

To hear how Zenzium can work for you contact

UK
Zenzium Ltd, BioHub at Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

E: info@zenzium.com

US
Zenzium, Inc. #228, 60 Thoreau Street, Concord, MA 01742, United States

E: info@zenzium.com

900-spacer

BioHub at Alderley Park